BPC-157 (Body Protection Compound-157) is a synthetic peptide fragment derived from a naturally occurring protein found in human gastric juice. It has become one of the most frequently referenced peptides in tissue-repair research, largely because of a substantial body of animal-model literature investigating its effects on tendon, ligament, muscle, and gut tissue.
Angiogenesis and Tissue Repair
A recurring theme across published rodent studies is BPC-157’s association with upregulated angiogenesis — the formation of new blood vessels — at sites of induced injury. Researchers have proposed this as a mechanistic explanation for accelerated healing observed in models of tendon transection and muscle crush injury.
Gastrointestinal Models
Given its origin in gastric tissue, a significant portion of the literature focuses on gut-related models, including studies on gastric ulceration and inflammatory bowel models in rodents, where BPC-157 administration has been associated with measurable protective effects on gut lining integrity.
Current Limitations in the Research
It’s worth noting plainly: the vast majority of BPC-157 literature to date consists of animal studies, and human clinical trial data remains extremely limited. Researchers working with this compound should treat rodent-model findings as hypothesis-generating rather than conclusive, and should always consult primary literature directly rather than secondary summaries when designing a study.
